Another treatment gap: Restarting secondary prevention medications: The Women's Health Initiative

Robinson, 2005, A “poly-portfolio” for secondary prevention: a strategy to reduce subsequent events by up to 97% over five years, Am J Cardiol, 95, 373, 10.1016/j.amjcard.2004.09.036 Setoguchi, 2008, Improvements in long-term mortality after myocardial infarction and increased use of cardiovascular drugs after discharge: a 10-year trend analysis, J Am Coll Cardiol, 51, 1247, 10.1016/j.jacc.2007.10.063 Smith, 2006, AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update: endorsed by the National Heart, Lung, and Blood Institute, J Am Coll Cardiol, 47, 2130, 10.1016/j.jacc.2006.04.026 Rasmussen, 2007, Relationship between adherence to evidence-based pharmacotherapy and long-term mortality after acute myocardial infarction, JAMA, 297, 177, 10.1001/jama.297.2.177 2003 Federman, 2001, Supplemental insurance and use of effective cardiovascular drugs among elderly Medicare beneficiaries with coronary heart disease, JAMA, 286, 1732, 10.1001/jama.286.14.1732 Ho, 2006, Impact of medication therapy discontinuation on mortality after myocardial infarction, Arch Intern Med, 166, 1842, 10.1001/archinte.166.17.1842 Albert, 2008, Factors associated with discharge lipid-lowering drug prescription in patients hospitalized for coronary artery disease (from the Get With the Guidelines Database), Am J Cardiol, 101, 1242, 10.1016/j.amjcard.2007.12.020 Stefanick, 2003, The Women's Health Initiative postmenopausal hormone trials: overview and baseline characteristics of participants, Ann Epidemiol, 13, S78, 10.1016/S1047-2797(03)00045-0 Ritenbaugh, 2003, The Women's Health Initiative Dietary Modification Trial: overview and baseline characteristics of participants, Ann Epidemiol, 13, S87, 10.1016/S1047-2797(03)00044-9 1998, Design of the Women's Health Initiative clinical trials and observational study, Control Clin Trials, 19, 61, 10.1016/S0197-2456(97)00078-0 2002, Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial, JAMA, 288, 321, 10.1001/jama.288.3.321 Hsia, 2006, Conjugated equine estrogens and coronary heart disease: the Women's Health Initiative, Arch Intern Med, 166, 357, 10.1001/archinte.166.3.357 Howard, 2006, Low-fat dietary pattern and risk of cardiovascular disease: the Women's Health Initiative randomized controlled dietary modification trial, JAMA, 295, 655, 10.1001/jama.295.6.655 Curb, 2003, Outcomes ascertainment and adjudication methods in the Women's Health Initiative, Ann Epidemiol, 13, S122, 10.1016/S1047-2797(03)00048-6 Setoguchi, 2008, Gender differences in the management and prognosis of myocardial infarction among patients ≥65 years of age, Am J Cardiol, 101, 1531, 10.1016/j.amjcard.2008.02.033 Jani, 2006, Sex differences in the application of evidence-based therapies for the treatment of acute myocardial infarction: the American College of Cardiology's Guidelines Applied in Practice Projects in Michigan, Arch Intern Med, 166, 1164, 10.1001/archinte.166.11.1164 Spencer, 2005, Decade-long changes in the use of combination evidence-based medical therapy at discharge for patients surviving acute myocardial infarction, Am Heart J, 150, 838, 10.1016/j.ahj.2004.11.005 Vaccarino, 2005, Sex and racial differences in the management of acute myocardial infarction, 1994 through 2002, N Engl J Med, 353, 671, 10.1056/NEJMsa032214 Brookhart, 2007, Physician follow-up and provider continuity are associated with long-term medication adherence: a study of the dynamics of statin use, Arch Intern Med, 167, 847, 10.1001/archinte.167.8.847 Newby, 2006, Long-term adherence to evidence-based secondary prevention therapies in coronary artery disease, Circulation, 113, 203, 10.1161/CIRCULATIONAHA.105.505636 Soumerai, 2006, Cost-related medication nonadherence among elderly and disabled Medicare beneficiaries: A national survey 1 year before the Medicare Drug Benefit, Arch Intern Med, 166, 1829, 10.1001/archinte.166.17.1829